Caplin Point: Subsidiary bags approval, stock up 3 per cent
Caplin Point: Subsidiary bags approval, stock up 3 per cent

Caplin Point: Subsidiary bags approval, stock up 3 per cent

Advait Dharmadhikari Article rating: 3.8

Caplin Steriles, a 100 per cent subsidiary of Caplin Point Laboratories has received final approval by the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Glycopyrrolate injection USP.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 2.94 crore contracts with a turnover of Rs. 18,85,084 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 2.94 crore contracts with a turnover of Rs. 18,85,084 crore.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 4.7

The markets on March 22, 2019 opened up. BSE Sensex is trading at 38,363.11, up by 23.64 points and the Nifty is trading at 11,512.75, down by 15.60 points. 

Tata Power bags Rs. 1,200 crore order
Tata Power bags Rs. 1,200 crore order

Tata Power bags Rs. 1,200 crore order

Pratik Shastri Article rating: 5.0

Tata Power, a Tata Group company, bagged a contract from the Ministry of Defence for air surveillance equipment. The company will work in partnership with foreign OEM, Indra Sistemas, Spain.

Investing in real estate with REITs
Investing in real estate with REITs

Investing in real estate with REITs

Henil Shah Article rating: 3.5

When it comes to investing in a real estate one requires a really big-ticket size, but not anymore as REITs are making their way to the Indian markets. So, should you consider investing in it? Read on to find out more.

RSS
First26422643264426452647264926502651Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR